Acer Therapeutics Inc.·4

Jan 19, 4:20 PM ET

DUNN JOHN MICHAEL 4

4 · Acer Therapeutics Inc. · Filed Jan 19, 2022

Insider Transaction Report

Form 4
Period: 2022-01-14
Transactions
  • Award

    Stock Option (right to buy)

    2022-01-14+18,50018,500 total
    Exercise: $2.21Exp: 2032-01-14Common Stock (18,500 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable in full on January 14, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION